Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of low doses of oligonucleotides antisense to TGF-β genes in the treatment of brain tumors

Use of low doses of oligonucleotides antisense to TGF-β genes in the treatment of brain tumors

US Patent 8097597 · Granted Jan 17, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stable polymorphic form of 6-fluoro-9-methyl-9H-β-carboline and uses thereof2025
Method for selective oligonucleotide modification2015
Dosage of oligonucleotides suitable for the treatment of tumors2014
Mixture comprising an inhibitor or suppressor of a gene and a molecule binding t2014
Mixture comprising an inhibitor or suppressor of a gene and a molecule binding t2014
Method for stimulating the immune system2014
Method for stimulating the immune system2014
Combination of a chemotherapeutic agent and an inhibitor of the TGF-beta system2013
Method for inhibiting “melanoma inhibitory activity” MIA2012
Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA2011
Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA2011
Antisense-oligonucleotides for the treatment of immuno-suppressive effects of tr2010